XIV Eurasian Hematology-Oncology Congress - EHOC 2023

 

Leukemia
17:15

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Clinical Case of BPDCN

FEATURING Hanan Hamed
  • 25 views
  • February 23, 2024
19:51

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

A 50-Year Personal Perspective on the Treatment of AML

FEATURING Charles A. Schiffer
  • 167 views
  • February 21, 2024
12:11

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Induction Therapy Choices and Responses of ALL in a Third World Country: A Single-Center Study From Pakistan

FEATURING Amjad Zafar
  • 18 views
  • February 16, 2024
14:43

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Is HSCT Necessary to Consolidate Hematological Remission After CAR-T in ALL?

FEATURING Francesco Saglio
  • 45 views
  • February 16, 2024
07:25

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

BK Virus Infections in Pediatric Leukemia During Treatment

FEATURING Dilek KaçAr
  • 17 views
  • February 16, 2024
08:11

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Molecular Characteristics and Treatment Response to COG-ALL Protocols in Pediatric Patients

FEATURING Bengisu GüNer Yılmaz
  • 12 views
  • February 16, 2024
13:09

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Inaticabtagene Autoleucel Treatment in Adult R/R B-Cell ALL in China

FEATURING Lyu Lulu
  • 9 views
  • February 16, 2024
16:52

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

CLL: Future Perspectives and Unanswered Questions

FEATURING Alessandra Ferrajoli
  • 218 views
  • February 16, 2024
15:36

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Debates in CLL: The Case for Combination Therapy in 1L

FEATURING Ahmad Ibrahim
  • 38 views
  • February 16, 2024
12:23

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Debates in CLL: The Case for BTKi Monotherapy in 1L

FEATURING Gerardo Musuraca
  • 70 views
  • February 16, 2024
06:14

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

CLL Case Presentation: 72 y/o Male With Cardiac Comorbidities

FEATURING Fatma Eda Nuhoğlu Kantarcı
  • 13 views
  • February 16, 2024
08:11

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

State-of-the-Art in CLL Treatment

FEATURING Antonio Cuneo
  • 509 views
  • February 16, 2024
  • 4
08:54

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Future Perspectives in CML

FEATURING Naeem Chaudhri
  • 17 views
  • February 16, 2024
07:46

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Debates in CML: Imatinib is NOT the Best Choice for 1L TKI

FEATURING Tomasz Sacha
  • 12 views
  • February 16, 2024
13:06

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Debates in CML: Imatinib is the Best Choice for 1L TKI

FEATURING Giuseppe Saglio
  • 10 views
  • February 16, 2024
14:31

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

CML Case Presentation: A Patient With Multiple TKI Failure

FEATURING Deniz Özmen İbiş
  • 11 views
  • February 16, 2024
12:22

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

CML Case Presentation: A Young Patient With TKI Intolerance and Resistance

FEATURING Carmen Fava
  • 12 views
  • February 16, 2024
14:44

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

CML: State-of-the-Art and Progress Towards Cure

FEATURING Pia Raanani
  • 14 views
  • February 16, 2024
20:06

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Current and Future Approaches to the Treatment of B- and T-ALL

FEATURING Dieter Hoelzer
  • 35 views
  • February 16, 2024
18:14

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Acute Promyelocytic Leukemia: Risk Stratification and New Treatment Modalities

FEATURING Suar ÇAkı Kılıç
  • 85 views
  • February 16, 2024
  • 1
16:07

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Pediatric AML: Diagnosis and Risk Stratification

FEATURING Nihal Karadaş
  • 179 views
  • February 16, 2024
26:45

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Therapeutic Challenges and BMT in Pediatric Patients With CML

FEATURING Talia Ileri
  • 9 views
  • February 16, 2024
26:32

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Pediatric CML Treatment Options and Management

FEATURING ÖZlem TüFekçI GüRocak
  • 15 views
  • February 16, 2024
08:29

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Effect of GVHD Prophylaxis on the Leukemia-Free Survival in Pediatric Patients Who Underwent HSCT for Leukemia

FEATURING Özge Aylin Boran
  • 20 views
  • February 15, 2024
15:56

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Pediatric CML Diagnosis

FEATURING Adalet Meral Güneş
  • 11 views
  • February 15, 2024
08:34

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Adults With ALL: When Not to Transplant

FEATURING Elias Jabbour
  • 40 views
  • February 15, 2024
13:19

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Adults With ALL: When to Transplant

FEATURING Sabina Chiaretti
  • 21 views
  • February 15, 2024
08:39

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Feasibilty of Therapy for Elderly Ph+ ALL Patients

FEATURING Giovanni Marconi
  • 28 views
  • February 15, 2024
15:43

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Recent Updates in ALL Treatment

FEATURING Giovanni Martinelli
  • 25 views
  • February 15, 2024
14:12

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Future Directions in AML: Optimizing Doublets and Triplets to Improve Efficacy and Maintain Safety

FEATURING Naval Daver
  • 58 views
  • February 15, 2024
05:14

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Case Discussion: Ven+Aza Maintanance After Intensive Induction in 33 y/o Intermediate-Risk AML Patient

FEATURING Mehmet Yilmaz
  • 11 views
  • February 15, 2024
11:17

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

State of the Art: Role of Maintenance Therapy in AML

FEATURING Zeba Aziz
  • 230 views
  • February 15, 2024